Vodafone Idea seeks clarity on AGR issue to secure debt funding

Vodafone Idea's CEO, Akshaya Moondra, stated that lenders are currently in a wait-and-watch mode regarding the company's debt-funding plans, pending clarity on the adjusted gross revenue (AGR) issue from the government. He expressed optimism about securing funding once the government addresses the AGR concerns, despite the recent Supreme Court ruling not favoring a re-computation of dues. Moondra emphasized ongoing engagement with banks to finalize funding once clarity is achieved.

UBS maintains buy rating for Novartis with price target of 111 francs

UBS has reaffirmed its Buy rating for Novartis, setting a price target of 111 francs, following insights from a recent conference. CFO Harry Kirsch expressed optimism about growth prospects for 2025, coinciding with the expiration of the Entresto patent, according to analyst Matthew Weston.
12:35 14.11.2024

gold prices tumble as us dollar strengthens post trump election victory

Gold prices have dropped over 4% following Donald Trump's election victory, despite expectations of lower tax rates and higher tariffs potentially increasing inflation and government debt. As of late Monday, gold was priced at $2,618 per ounce, down from a recent high of approximately $2,800. The decline is partly attributed to a strengthening U.S. dollar, making gold more expensive for foreign buyers.

ubs maintains neutral rating for heidelberg materials with target price of 106 euros

UBS AG has maintained a "Neutral" rating for Heidelberg Materials, setting a target price of 106 euros after discussions on a new cost-cutting program. The analyst noted a positive industry environment, with companies enjoying pricing power in the USA and Europe. As of midday trading, shares rose by 0.3% to EUR 118.90, indicating a potential decline of 10.85% from the target price.
12:34 14.11.2024

ubs maintains buy rating for siemens with target price of 200 euros

UBS AG maintains a "Buy" rating for Siemens shares with a target price of 200 euros, following positive financial results for the 2024/25 fiscal year. The company exceeded expectations in its core business, with shares rising 5.6% in XETRA trading, reflecting a 14.7% increase since the start of 2024. Key figures for Q4 2024 are set to be released on November 14, 2024.
12:34 14.11.2024

pfizer inc maintains strong market position with diverse product offerings

Pfizer Inc. is a leading global pharmaceutical company, with net sales primarily from primary care products (52.3%), specialty care products (25.6%), and oncology products (19.9%). Geographically, sales are distributed with 42.3% in the United States, 21.9% in Europe, and 33.8% in other regions.
12:33 14.11.2024

ubs maintains buy rating for novartis with target of 111 francs

UBS has maintained its 'Buy' rating for Novartis, setting a price target of 111 francs. CFO Harry Kirsch expressed optimism about the company's growth prospects for 2025, coinciding with the expiration of the Entresto patent, according to analyst Matthew Weston.
12:31 14.11.2024

Nifty faces potential decline as bearish sentiment persists near key support level

The Nifty 50 continued its downtrend, closing at 23,533, marking its lowest since June 21, and forming a Gravestone Doji candlestick pattern, indicating bearish sentiment. Experts suggest that if the index falls below the 200-day EMA of 23,542, it could target 23,200, while immediate resistance is seen at 23,800. A "sell on rise" strategy is recommended as the index remains in an oversold zone.

ubs maintains neutral rating for pfizer with target price of 31 dollars

UBS has maintained a 'Neutral' rating for Pfizer, setting a target price of 31 US dollars. Analyst Trung Huynh noted that the pharmaceutical company is starting to regain investor confidence after a mixed performance this year.
12:30 14.11.2024

ubs raises alstom target price to 20 euros maintains neutral rating

UBS has raised its target price for Alstom from 19 to 20 euros while maintaining a "Neutral" rating. Analyst Andre Kukhnin noted that the train manufacturer is on track for more predictable results, supported by solid half-year performance and improved free cash flow estimates. Alstom's net sales are primarily derived from rolling stock, railway services, signaling systems, and infrastructure, with significant revenue from Europe and the Americas.
12:30 14.11.2024
Trending
Subcategory:
Countries:
Companies:
Currencies:
People:

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings